Does biotech and healthcare offer a long-term growth story for investment companies?
Innovation in biotechnology and healthcare: a long-term growth story for investment companies?
Why invest in biotechnology and healthcare?
A manager’s best investment: Oxford Pharmasciences
Daniel Mahony, Manager of Polar Capital Global Healthcare Growth & Income discusses the outlook for the sector
Carl Harald Janson, Manager of International Biotechnology Trust, explains the case for investing in biotech and healthcare
Latest articles and press releases.
The AIC today responds to the Commission’s action plan for building a capital markets union.
Data from Matrix Financial Clarity reveals that investment company purchases on platforms by advisers and wealth managers reached a new record high of £260.8m in Q2 2015.
View more news
AIC StatsDownload the latest AIC Stats publications.
www.aicstats.co.ukView the interactive version of the AIC Stats where you can rank and compare companies.
Download the latest industry overview data.
Find and compare investment companiesUse our search to find a company, and click through for detailed data which is updated each day.
News content provided by Citywire.
A dividend cut at BlackRock World Mining looks unavoidable but some investors are buying shares in the battered investment trust.
The Greek debt crisis, China's troubles and the VW scandal made it a tough third quarter, but some investment trusts weathered the storm.
Chief executive will continue to run Alliance Trust Investments but her influence is diminished in big shake-up to improve performance.
More Citywire news